Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
FuFangCongRongYiZhiJiaoNang
- Development stage
- Phase 4
- Lead developer
- Beijing University of Chinese Medicine
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
FuFangCongRongYiZhiJiaoNang (Compound Congrong Yizhi Capsule) is a marketed traditional Chinese patent medicine approved in China for the treatment of mild-to-moderate vascular dementia (VaD) and vascular cognitive impairment (VCI). It is a multi-herb formulation composed of five natural ingredients: *Cistanche deserticola* (肉苁蓉), *Fallopia multiflora* (制何首乌), *Nelumbo nucifera* (荷叶), *Pheretima aspergillum* (地龙), and *Rhaponticum uniflorum* (漏芦). The capsule is designed to nourish the liver and kidneys, activate blood circulation, and resolve phlegm to improve cognitive function, memory, and daily living activities. It is manufactured by companies such as Lei Yun Shang Pharmaceutical Group and Liaoyuan Yulong Yadong Pharmaceutical, and is being evaluated in Phase 4 clinical trials for the prevention of cognitive impairment after stroke and intracerebral hemorrhage.
- Brand names
- Lei Yun Shang雷允上
- Other names
- CCYCCompound Congrong Yizhi CapsuleCompound Congrong Yizhi CapsulesCongsheng CapsuleFCYCFufang Congrong Yizhi CapsuleFufang Congrong Yizhi Capsules复方苁蓉益智胶囊
Beyond the preview
Go deeper on FuFangCongRongYiZhiJiaoNang.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FuFangCongRongYiZhiJiaoNang.